Success Story: Without RFE! Our Firm Helped a Chinese Senior Scientist Achieve Success With Our Expert Assistance
Client’s Testimonial:
“North America Immigration Law Group provided outstanding guidance throughout my NIW process. Their team clearly understood my research and presented my contributions with exceptional skill. They were responsive, thorough, and highly professional at every step. Thanks to their strategic support, my case was approved without an RFE. I’m truly grateful for their work and strongly recommend North America Immigration Law Group to other researchers.”
On December 5th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: December 5th, 2025
Processing Time: 14 months, 16 days
Case Summary:
Our firm is pleased to announce another successful outcome achieved through the expert guidance of North America Immigration Law Group (NAILG). The client, an accomplished researcher in the field of bioinformatics, has built a career focused on advancing artificial intelligence and natural language processing (NLP) technologies to accelerate biomedical discovery. With NAILG’s strategic guidance, the client’s I-140 National Interest Waiver (NIW) petition was approved, reflecting both the scientific significance of the client’s work and the strength of the legal case presented.
Advancing AI-Enabled Drug Discovery for National Health Priorities
Holding a Ph.D. in Computer Science, the client’s proposed endeavor centers on developing advanced NLP methodologies to improve the prediction of biomolecular functions and the identification of druggable targets. This research directly supports the discovery of new treatments for life-threatening diseases, including endometrial cancer, non-small cell lung cancer, and other malignant neoplasms. By creating more accurate computational tools for target discovery, the client’s work contributes to fields formally recognized by the U.S. government as critical and emerging technologies, including machine learning, bioinformatics, computational biology, and generative AI systems.
A Record of Scientific Excellence and Peer-Recognized Impact
The client’s achievements are reflected in a strong and influential publication record, including:
- 8 peer-reviewed journal articles (5 of them co-first-authored)
- 3 peer-reviewed conference articles (including 1 first-authored)
- 1 co-first-authored abstract
- 2 preprints (including 1 first-authored)
Collectively, this body of work has been cited 212 times, demonstrating substantial uptake and reliance on the client’s research by independent investigators around the world. Many of these publications appear in highly ranked venues in bioinformatics and AI, underscoring their scientific merit and relevance.
In addition to the strong publication record, the client has been invited to serve as a peer reviewer for prominent journals and conferences, completing at least 30 reviews to date. Such invitations are extended only to specialists recognized for their expertise, confirming the client’s status as a trusted contributor in the advancement of AI-enabled biological research.
Furthermore, the client’s work has been supported by major U.S. funding sources, including the National Institutes of Health, the Army Research Office, and the Agency for Healthcare Research and Quality, all of which prioritize research that directly serves national scientific and public health interests.
Support from Experts in the Field
The NIW petition included four expert recommendation letters, each attesting to the client’s technical skill, scientific creativity, and the importance of the proposed research direction. These letters provided crucial third-party validation of the client’s influence and the significance of the ongoing work.
“Therefore, [Client’s] review service illustrates his recognition as an expert in the bioinformatics community.”
A Strong Approval Reflecting Clear National Importance
Through NAILG’s comprehensive presentation of the case, the NIW petition was approved without delay. This favorable outcome affirms both the client’s contributions to the expanding intersection of artificial intelligence and biomedical science and the critical need for continued innovation in drug discovery technologies.
Our firm is proud to support a researcher whose work strengthens the United States’ leadership in AI, life sciences, and public health innovation. The client’s achievements represent meaningful progress toward more effective diagnostics and treatments for some of the most deadly diseases affecting Americans and populations worldwide.